| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Dhananjaya V. Kalvakolanu | |
| P2860 | cites work | A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients | Q22007941 |
| Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein | Q22010192 | ||
| Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes | Q22254125 | ||
| Limitin: An interferon-like cytokine that preferentially influences B-lymphocyte precursors | Q22254187 | ||
| Functional role of type I and type II interferons in antiviral defense | Q24276429 | ||
| Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase | Q24290751 | ||
| Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation | Q24290901 | ||
| A transcriptional corepressor of Stat1 with an essential LXXLL signature motif | Q24290918 | ||
| Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells | Q24291206 | ||
| The human interferon- and estrogen-regulated ISG20/HEM45 gene product degrades single-stranded RNA and DNA in vitro | Q24291320 | ||
| The locus-specific enhancer activity of the class I major histocompatibility complex interferon-responsive element is associated with a gamma-interferon (IFN)-inducible factor distinct from STAT1alpha, p48, and IFN regulatory factor-1. | Q41150401 | ||
| ISGF3 gamma p48, a specificity switch for interferon activated transcription factors | Q41157748 | ||
| Activation of protein kinase A inhibits interferon induction of the Jak/Stat pathway in U266 cells | Q41224915 | ||
| The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite | Q41260447 | ||
| Cognate DNA binding specificity retained after leucine zipper exchange between GCN4 and C/EBP. | Q41267086 | ||
| Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2. | Q41293458 | ||
| Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway | Q41361506 | ||
| Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: role for endogenous IFN-beta | Q41374783 | ||
| GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. | Q41404184 | ||
| Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction | Q41434003 | ||
| Activation of the protein tyrosine kinase tyk2 by interferon alpha/beta | Q41454373 | ||
| Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. | Q41457392 | ||
| Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. | Q41460849 | ||
| Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway | Q41514580 | ||
| NF-IL6 and NF-kappa B in cytokine gene regulation | Q41545806 | ||
| Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta | Q41609229 | ||
| Interferon regulatory factor-1 is inducible by prolactin, interleukin-2 and concanavalin A in T cells | Q41617442 | ||
| Signal transduction through MAP kinase cascades | Q41750250 | ||
| Terminal differentiation of myeloleukemic M1 cells induced by IL-6: role of endogenous interferon | Q42083756 | ||
| Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. | Q42123661 | ||
| Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes | Q42513731 | ||
| Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling | Q42673076 | ||
| Vaccinia Virus B18R Gene Encodes a Type I Interferon-binding Protein That Blocks Interferon α Transmembrane Signaling | Q42679205 | ||
| The carboxyl terminus of interferon-gamma contains a functional polybasic nuclear localization sequence | Q42823288 | ||
| KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway | Q42834462 | ||
| The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo | Q42943882 | ||
| Interferon-beta is required for interferon-alpha production in mouse fibroblasts | Q43412872 | ||
| Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain | Q43498366 | ||
| Cross talk of the interferon-alpha/beta signalling complex with gp130 for effective interleukin-6 signalling | Q43688291 | ||
| Interferon alpha2b increases paracellular permeability of renal proximal tubular LLC-PK1 cells via a mitogen activated protein kinase signaling pathway | Q43703540 | ||
| Involvement of the IRF-1 transcription factor in antiviral responses to interferons | Q44518832 | ||
| Inhibition of IFN-gamma signaling by an Epstein-Barr virus immediate-early protein | Q45734610 | ||
| Possible involvement of the transcription factor ISGF3 gamma in virus-induced expression of the IFN-beta gene | Q45784282 | ||
| The growing family of interferon regulatory factors | Q47992425 | ||
| Modulation of interferon action by retinoids. Induction of murine STAT1 gene expression by retinoic acid | Q48051237 | ||
| A novel member of the interferon receptor family complements functionality of the murine interferon gamma receptor in human cells | Q48084253 | ||
| LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein | Q48255574 | ||
| Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. | Q50335883 | ||
| Regulation of the activity of MEK kinase 1 (MEKK1) by autophosphorylation within the kinase activation domain | Q28506778 | ||
| An essential role for C/EBPbeta in female reproduction | Q28507381 | ||
| Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction | Q28513103 | ||
| IRF family of transcription factors as regulators of host defense | Q28513569 | ||
| Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha | Q28513836 | ||
| Constitutive nuclear localization of Janus kinases 1 and 2 | Q28565323 | ||
| IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP | Q28575310 | ||
| MEKK1 phosphorylates MEK1 and MEK2 but does not cause activation of mitogen-activated protein kinase | Q28581201 | ||
| Structure and function of a new STAT-induced STAT inhibitor | Q28584775 | ||
| The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo | Q28588059 | ||
| Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo | Q28609049 | ||
| Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction | Q28609565 | ||
| Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8 | Q28609808 | ||
| Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6 | Q28609813 | ||
| Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme | Q28610362 | ||
| Requirement of serine phosphorylation for formation of STAT-promoter complexes | Q28637366 | ||
| Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein | Q28646262 | ||
| The Jak kinases differentially associate with the alpha and beta (accessory factor) chains of the interferon gamma receptor to form a functional receptor unit capable of activating STAT transcription factors | Q28646350 | ||
| Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process | Q28646352 | ||
| Identification of an interferon-gamma receptor alpha chain sequence required for JAK-1 binding | Q28646364 | ||
| Catalytically active TYK2 is essential for interferon-beta-mediated phosphorylation of STAT3 and interferon-alpha receptor-1 (IFNAR-1) but not for activation of phosphoinositol 3-kinase | Q28646398 | ||
| Tyrosine-phosphorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3 | Q28646506 | ||
| Transcription factor ISGF-3 formation requires phosphorylated Stat91 protein, but Stat113 protein is phosphorylated independently of Stat91 protein | Q28646517 | ||
| Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase | Q28646526 | ||
| Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays | Q28646554 | ||
| STATs and gene regulation | Q29547796 | ||
| Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease | Q29615967 | ||
| Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway | Q29615968 | ||
| Identification of a novel inhibitor of mitogen-activated protein kinase kinase | Q29616448 | ||
| Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome | Q29616850 | ||
| Cellular responses to interferon-gamma | Q29618567 | ||
| Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction | Q29620054 | ||
| Viruses and interferons | Q29620788 | ||
| The CrkL adapter protein is required for type I interferon-dependent gene transcription and activation of the small G-protein Rap1. | Q30167565 | ||
| Activation of a CrkL-stat5 signaling complex by type I interferons. | Q30175923 | ||
| A transcription factor with SH2 and SH3 domains is directly activated by an interferon alpha-induced cytoplasmic protein tyrosine kinase(s) | Q30195316 | ||
| Interferon-kappa, a novel type I interferon expressed in human keratinocytes | Q24291586 | ||
| C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival | Q24291845 | ||
| Activities of IRF-1 | Q24292304 | ||
| IRF-1 as a negative regulator of cell proliferation | Q24292306 | ||
| Molecular cloning and expression of the human interferon-gamma receptor | Q24294544 | ||
| Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc | Q24294647 | ||
| Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes | Q24295016 | ||
| Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins | Q24296810 | ||
| Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA | Q24300964 | ||
| Identification of a nuclear Stat1 protein tyrosine phosphatase | Q24302061 | ||
| Inhibition of Stat1-mediated gene activation by PIAS1 | Q24310082 | ||
| A family of cytokine-inducible inhibitors of signalling | Q24313168 | ||
| A new protein containing an SH2 domain that inhibits JAK kinases | Q24313242 | ||
| Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene | Q24313328 | ||
| The human interferon alpha/beta receptor: characterization and molecular cloning | Q24313421 | ||
| Stat2 is a transcriptional activator that requires sequence-specific contacts provided by stat1 and p48 for stable interaction with DNA | Q24318311 | ||
| The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction | Q24319109 | ||
| A protein-arginine methyltransferase binds to the intracytoplasmic domain of the IFNAR1 chain in the type I interferon receptor | Q24319127 | ||
| PACT, a protein activator of the interferon-induced protein kinase, PKR. | Q24319677 | ||
| Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein | Q24323485 | ||
| Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor | Q24336191 | ||
| The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32 | Q24336213 | ||
| NF-kappa B and C/EBP transcription factor families synergistically function in mouse serum amyloid A gene expression induced by inflammatory cytokines | Q24336834 | ||
| Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling | Q24337125 | ||
| Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity | Q24531180 | ||
| MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42 | Q24532640 | ||
| Identification of novel stress-induced genes downstream of chop | Q24533261 | ||
| Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7 | Q24533409 | ||
| Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein | Q24536345 | ||
| A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein | Q24537405 | ||
| CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation | Q24551176 | ||
| The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction | Q24564242 | ||
| Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain | Q24604330 | ||
| A single DNA response element can confer inducibility by both alpha- and gamma-interferons | Q24626821 | ||
| Interferon-stimulated transcription: isolation of an inducible gene and identification of its regulatory region | Q24628753 | ||
| Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes | Q24643507 | ||
| STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation | Q24644334 | ||
| Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex | Q24647642 | ||
| Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling | Q24658040 | ||
| Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP | Q24679086 | ||
| MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta | Q24681806 | ||
| Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein | Q24683287 | ||
| Cell signaling by receptor tyrosine kinases | Q27860474 | ||
| The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins | Q27860587 | ||
| How cells respond to interferons | Q27861006 | ||
| Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1 | Q28114883 | ||
| A protein tyrosine kinase in the interferon alpha/beta signaling pathway | Q28116574 | ||
| Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions | Q28118180 | ||
| Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2 | Q28118615 | ||
| PKR; a sentinel kinase for cellular stress | Q28137774 | ||
| Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBP beta is required for hepatocyte proliferation induced by TGF alpha | Q28142640 | ||
| GTP binding by class II transactivator: role in nuclear import | Q28143079 | ||
| Stat protein transactivation domains recruit p300/CBP through widely divergent sequences | Q28143105 | ||
| Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection | Q28144181 | ||
| MEKK1 binds raf-1 and the ERK2 cascade components | Q28145204 | ||
| Virus interference. I. The interferon | Q28181608 | ||
| Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250 | Q28199910 | ||
| The polyoma virus T antigen interferes with interferon-inducible gene expression | Q35791333 | ||
| The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines | Q35886322 | ||
| Transcription factors induced by interferons alpha and gamma | Q35888238 | ||
| Interferon gamma-induced transcription of the murine ISGF3gamma (p48) gene is mediated by novel factors | Q35901315 | ||
| Cells resistant to interferon are defective in activation of a promoter-binding factor. | Q35996080 | ||
| A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis | Q36084388 | ||
| STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities | Q36091763 | ||
| Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice | Q36173122 | ||
| Stat1-independent regulation of gene expression in response to IFN-gamma | Q36231607 | ||
| Biologic consequences of Stat1-independent IFN signaling. | Q36231950 | ||
| The intracellular domain of interferon-alpha receptor 2c (IFN-alphaR2c) chain is responsible for Stat activation | Q36335491 | ||
| Role of interferon regulatory factor 1 in induction of nitric oxide synthase | Q36363736 | ||
| Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis | Q36376889 | ||
| Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression | Q36380813 | ||
| Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway | Q36400431 | ||
| Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice | Q36497106 | ||
| Identification of a yeast artificial chromosome clone encoding an accessory factor for the human interferon gamma receptor: evidence for multiple accessory factors | Q36550063 | ||
| Ligand-induced association of the type I interferon receptor components | Q36553478 | ||
| Evidence for posttranscriptional regulation of C/EBPalpha and C/EBPbeta isoform expression during the lipopolysaccharide-mediated acute-phase response | Q36559345 | ||
| Transcriptional induction of the alpha-1 acid glycoprotein (AGP) gene by synergistic interaction of two alternative activator forms of AGP/enhancer-binding protein (C/EBP beta) and NF-kappaB or Nopp140. | Q36561393 | ||
| The ability of C/EBP beta but not C/EBP alpha to synergize with an Sp1 protein is specified by the leucine zipper and activation domain | Q36567620 | ||
| Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins | Q36570254 | ||
| Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis | Q36571893 | ||
| The interferon-inducible murine p48 (ISGF3gamma) gene is regulated by protooncogene c-myc | Q36652856 | ||
| Two domains of ISGF3 gamma that mediate protein-DNA and protein-protein interactions during transcription factor assembly contribute to DNA-binding specificity | Q36658770 | ||
| Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription | Q36659852 | ||
| A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter | Q36659988 | ||
| Involvement of the transcription factor PU.1/Spi-1 in myeloid cell-restricted expression of an interferon-inducible gene encoding the human high-affinity Fc gamma receptor | Q36662265 | ||
| The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds | Q36689696 | ||
| Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction | Q36689762 | ||
| Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma uses a different signaling pathway | Q36704173 | ||
| Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells | Q36705872 | ||
| Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon- and interferon-stimulated genes but is not a primary transcriptional activator of either | Q36709682 | ||
| On the role of IRF in host defense | Q28201598 | ||
| Control of IRF-3 activation by phosphorylation | Q28201609 | ||
| Nuclear/cytoplasmic localization of IRFs in response to viral infection or interferon stimulation | Q28201619 | ||
| IRF-4 activities in HTLV-I-induced T cell leukemogenesis | Q28201628 | ||
| ICSBP/IRF-8: its regulatory roles in the development of myeloid cells | Q28201638 | ||
| The bare lymphocyte syndrome and the regulation of MHC expression | Q28204378 | ||
| Enhanceosomes | Q28204862 | ||
| Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells | Q28204912 | ||
| Protein inhibitors of activated STAT resemble scaffold attachment factors and function as interacting nuclear receptor coregulators | Q28205038 | ||
| Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 | Q28215945 | ||
| A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia | Q28253771 | ||
| The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein | Q28255013 | ||
| Specific inhibition of Stat3 signal transduction by PIAS3 | Q28255665 | ||
| Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia | Q28266438 | ||
| Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells | Q28276215 | ||
| Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha | Q28277620 | ||
| CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription | Q28287446 | ||
| Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme | Q28287610 | ||
| Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation | Q28288257 | ||
| Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha | Q28289207 | ||
| Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption | Q28290282 | ||
| Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha | Q28292603 | ||
| A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro | Q28296697 | ||
| Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action | Q28297833 | ||
| A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma | Q28298440 | ||
| A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection | Q28299361 | ||
| Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection | Q28299370 | ||
| Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors | Q28302411 | ||
| Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock | Q28307404 | ||
| Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase | Q30450248 | ||
| Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway | Q30452664 | ||
| Proteome analysis reveals ubiquitin-conjugating enzymes to be a new family of interferon-alpha-regulated genes. | Q30598957 | ||
| CCAAT/enhancer-binding protein-beta regulates interferon-induced transcription through a novel element | Q30860699 | ||
| CCAAT/enhancer-binding protein beta mediates interferon-gamma-induced p48 (ISGF3-gamma ) gene transcription in human monocytic cells | Q30987795 | ||
| The p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor | Q31076639 | ||
| Arginine/lysine-rich structural element is involved in interferon-induced nuclear import of STATs | Q31813086 | ||
| Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). | Q33541966 | ||
| An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes | Q33582885 | ||
| Virus interception of cytokine-regulated pathways | Q33601962 | ||
| Immunoregulatory properties of ISG15, an interferon-induced cytokine | Q33610088 | ||
| Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6 | Q33630682 | ||
| Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. | Q33649357 | ||
| MAP kinase pathways | Q33650641 | ||
| A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses | Q33771205 | ||
| Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid | Q33781496 | ||
| Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53 | Q33834993 | ||
| ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains | Q33877936 | ||
| Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB | Q33886023 | ||
| STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-gamma | Q33887011 | ||
| RNase-L-dependent destabilization of interferon-induced mRNAs. A role for the 2-5A system in attenuation of the interferon response | Q33893743 | ||
| Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1). | Q33894724 | ||
| Interferons and cell growth control | Q33917579 | ||
| Partial impairment of cytokine responses in Tyk2-deficient mice | Q33924660 | ||
| Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function | Q33924665 | ||
| Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription | Q33938819 | ||
| SUMO, ubiquitin's mysterious cousin | Q33939449 | ||
| The role of STATs in transcriptional control and their impact on cellular function | Q33941346 | ||
| Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53 | Q33957610 | ||
| Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder | Q33961815 | ||
| Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor | Q33966269 | ||
| Novel functions of interferon-induced proteins | Q33998145 | ||
| Second-generation interferons for cancer: clinical targets | Q33998161 | ||
| MEKK1 plays a critical role in activating the transcription factor C/EBP-beta-dependent gene expression in response to IFN-gamma | Q34030536 | ||
| Gene induction by interferons: functional complementation between trans-acting factors induced by alpha interferon and gamma interferon | Q36727058 | ||
| Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. | Q36735213 | ||
| A nuclear tyrosine phosphatase downregulates interferon-induced gene expression | Q36827566 | ||
| MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. | Q36967719 | ||
| IFN consensus sequence binding protein potentiates STAT1-dependent activation of IFNgamma-responsive promoters in macrophages. | Q37142588 | ||
| Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha | Q37166522 | ||
| Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways | Q37354287 | ||
| Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA | Q37467119 | ||
| Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation | Q37583264 | ||
| Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene | Q37590901 | ||
| Stat1 depends on transcriptional synergy with Sp1. | Q38287839 | ||
| Concerted participation of NF-kappa B and C/EBP heteromer in lipopolysaccharide induction of serum amyloid A gene expression in liver | Q38297326 | ||
| The myxoma virus-soluble interferon-gamma receptor homolog, M-T7, inhibits interferon-gamma in a species-specific manner | Q38298667 | ||
| Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon | Q38299121 | ||
| Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages | Q38299607 | ||
| An essential role for Daxx in the inhibition of B lymphopoiesis by type I interferons | Q38299652 | ||
| Genomic organization and transcriptional regulation of human Apo2/TRAIL gene. | Q38306226 | ||
| How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene | Q38309989 | ||
| Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development | Q38315288 | ||
| Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system | Q38317411 | ||
| p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons | Q38319422 | ||
| Activation of the p38 mitogen-activated protein kinase by type I interferons | Q38319686 | ||
| Interleukin-6 induces the (2'-5') oligoadenylate synthetase gene in M1 cells through an effect on the interferon-responsive enhancer | Q38336338 | ||
| Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors. | Q38353132 | ||
| CCAAT box enhancer binding protein alpha (C/EBP-alpha) stimulates kappaB element-mediated transcription in transfected cells | Q38360591 | ||
| Examination of the potential functional role of conserved cysteine residues in the hormone binding domain of the human 1,25-dihydroxyvitamin D3 receptor. | Q38361181 | ||
| Regulation of interferon-beta gene: structure and function of cis-elements and trans-acting factors | Q38750326 | ||
| Cooperation of STAT-1 and IRF-1 in interferon-gamma-induced transcription of the gp91(phox) gene | Q39152033 | ||
| Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB. | Q39446101 | ||
| Interferon consensus sequence binding protein confers resistance against Yersinia enterocolitica | Q39514613 | ||
| Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription | Q39589711 | ||
| Escape of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression | Q39595303 | ||
| The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation | Q39596942 | ||
| Interferon action against human parainfluenza virus type 3: involvement of a novel antiviral pathway in the inhibition of transcription | Q39602796 | ||
| Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation | Q34086182 | ||
| Structure and function of IRF-7. | Q34114255 | ||
| Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities | Q34132119 | ||
| The human interferon alpha species and receptors | Q34136286 | ||
| Interferon gamma signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain | Q34219840 | ||
| The interferon system and interferon regulatory factor transcription factors -- studies from gene knockout mice | Q34234067 | ||
| A weak signal for strong responses: interferon-alpha/beta revisited | Q34238056 | ||
| Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses. | Q34244880 | ||
| Cloning of murine interferon gamma receptor cDNA: expression in human cells mediates high-affinity binding but is not sufficient to confer sensitivity to murine interferon gamma | Q34325708 | ||
| Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways | Q34325874 | ||
| Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells | Q34326864 | ||
| Interferon-alfa-based treatment of chronic myeloid leukemia and implications of signal transduction inhibition | Q34349068 | ||
| Direct association of STAT3 with the IFNAR-1 chain of the human type I interferon receptor | Q34378837 | ||
| Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor | Q34379342 | ||
| Initiation factor eIF2 alpha phosphorylation in stress responses and apoptosis. | Q34383407 | ||
| A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases | Q34455419 | ||
| Signal integration via PKR. | Q34467907 | ||
| Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity | Q34532143 | ||
| Overlapping and distinct mechanisms regulating IRF-3 and IRF-7 function | Q34532718 | ||
| Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback | Q34532725 | ||
| The role of IRF-4 in B and T cell activation and differentiation | Q34532740 | ||
| The role of IRF-4 in transcriptional regulation | Q34532748 | ||
| ICSBP/IRF-8 transactivation: a tale of protein-protein interaction | Q34532757 | ||
| Nuclear export signal located within theDNA-binding domain of the STAT1transcription factor | Q34679479 | ||
| Cytokine therapeutics: lessons from interferon alpha | Q35033232 | ||
| Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53. | Q35197148 | ||
| Cytokine triggered molecular pathways that control cell cycle arrest | Q35345229 | ||
| Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. | Q35358944 | ||
| Retracted: Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors | Q35656534 | ||
| Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene | Q35776542 | ||
| SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. | Q52174469 | ||
| The role of C/EBP genes in adipocyte differentiation. | Q52182559 | ||
| Role of the isoforms of CCAAT/enhancer-binding protein in the initiation of phosphoenolpyruvate carboxykinase (GTP) gene transcription at birth. | Q52192519 | ||
| Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice. | Q52199698 | ||
| Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. | Q52507356 | ||
| Type I IFN modulates innate and specific antiviral immunity. | Q52920823 | ||
| ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. | Q53437189 | ||
| Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. | Q53517183 | ||
| Nuclease-resistant composite 2',5'-oligoadenylate-3', 5'-oligonucleotides for the targeted destruction of RNA: 2-5A-iso-antisense. | Q54137592 | ||
| Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. | Q54196124 | ||
| Partial Interferon‐γ Receptor Signaling Chain Deficiency in a Patient with Bacille Calmette‐Guérin andMycobacterium abscessusInfection | Q56941623 | ||
| Retinoic acid induces signal transducer and activator of transcription (STAT) 1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons | Q57054948 | ||
| Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro | Q57055052 | ||
| The Role of C/EBP Isoforms in the Control of Inflammatory and Native Immunity Functions | Q57272895 | ||
| Negative Modulation of Membrane Localization of the Raf-1 Protein Kinase by Hyperphosphorylation | Q58197205 | ||
| Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras | Q58666576 | ||
| An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes | Q59067290 | ||
| Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage | Q59081725 | ||
| α-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences | Q59089879 | ||
| Interferon-gamma-Induced MHC Class I Expression and Defects in Jak/Stat Signalling in Methylcholanthrene-Induced Sarcomas | Q61698896 | ||
| Immune response in mice that lack the interferon-gamma receptor | Q62022366 | ||
| Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor | Q68007089 | ||
| A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA | Q68033053 | ||
| Cloning members of protein-tyrosine kinase family using polymerase chain reaction | Q68065035 | ||
| JAK2, a third member of the JAK family of protein tyrosine kinases | Q68187981 | ||
| Tumor necrosis factor alpha promotes nuclear localization of cytokine-inducible CCAAT/enhancer binding protein isoforms in hepatocytes | Q71143996 | ||
| Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway | Q71468319 | ||
| Induction of the C/EBP beta gene by dexamethasone and glucagon in primary-cultured rat hepatocytes | Q71586807 | ||
| Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins | Q71768175 | ||
| The oncogenic transcription factor IRF-2 possesses a transcriptional repression and a latent activation domain | Q72351854 | ||
| Interleukin-6 modulates interferon-regulated gene expression by inducing the ISGF3 gamma gene using CCAAT/enhancer binding protein-beta(C/EBP-beta) | Q72999285 | ||
| Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases | Q73041199 | ||
| The vav proto-oncogene product (p95vav) interacts with the Tyk-2 protein tyrosine kinase | Q73085064 | ||
| Nuclear receptor coactivators | Q73153183 | ||
| CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling | Q73291750 | ||
| Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA | Q73398802 | ||
| Multistage regulation of Th1-type immune responses by the transcription factor IRF-1 | Q73479951 | ||
| Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo | Q73479956 | ||
| Signaling pathways to the assembly of an interferon-beta enhanceosome. Chemical genetic studies with a small molecule | Q73626309 | ||
| Impaired alpha-interferon signaling in transitional cell carcinoma: lack of p48 expression in 5637 cells | Q73698382 | ||
| HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators | Q73787690 | ||
| Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains | Q73943058 | ||
| The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins | Q73947973 | ||
| Interferon-alpha promotes survival of human primary B-lymphocytes via phosphatidylinositol 3-kinase | Q73987475 | ||
| Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages | Q74165184 | ||
| A role for NF-kappa B in the induction of beta-R1 by interferon-beta | Q74601721 | ||
| Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter | Q77522390 | ||
| Precursor processing of pro-ISG15/UCRP, an interferon-beta-induced ubiquitin-like protein | Q78151565 | ||
| Interferon-gamma-dependent nuclear import of Stat1 is mediated by the GTPase activity of Ran/TC4 | Q95793006 | ||
| Constitutive and IFN-gamma-induced nuclear import of STAT1 proceed through independent pathways | Q39646499 | ||
| Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons | Q39748096 | ||
| Role of STAT2 in the alpha interferon signaling pathway | Q40015757 | ||
| Differentiation-regulated serine phosphorylation of STAT1 promotes GAF activation in macrophages | Q40016551 | ||
| Ligand-induced assembly and activation of the gamma interferon receptor in intact cells | Q40019119 | ||
| C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter | Q40019700 | ||
| Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency | Q40020928 | ||
| Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase | Q40023873 | ||
| Regulation of the interferon-induced PKR: can viruses cope? | Q40399961 | ||
| Cytokine receptor signalling | Q40416594 | ||
| Signaling through the hematopoietic cytokine receptors. | Q40444894 | ||
| Cytokine signal transduction and the JAK family of protein tyrosine kinases | Q40668096 | ||
| The virus-induced factor VIF differentially recognizes the virus-responsive modules of the mouse IFNA4 gene promoter | Q40750832 | ||
| A non-classical ISRE/ISGF3 pathway mediates induction of RANTES gene transcription by type I IFNs | Q40753511 | ||
| Role of nucleoporin induction in releasing an mRNA nuclear export block | Q40754912 | ||
| Specific inhibition of interferon signal transduction pathways by adenoviral infection | Q40773522 | ||
| Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation | Q40792689 | ||
| The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. | Q40808240 | ||
| ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma | Q40854135 | ||
| Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection | Q40863327 | ||
| Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways | Q40874268 | ||
| Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway | Q40891423 | ||
| Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling | Q40990146 | ||
| Activation of Raf-1 by interferon gamma and oncostatin M requires expression of the Stat1 transcription factor | Q41024206 | ||
| Interferon gamma activation of Raf-1 is Jak1-dependent and p21ras-independent | Q41063440 | ||
| Differential use of CREB binding protein-coactivator complexes | Q41064392 | ||
| Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases | Q41075291 | ||
| The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. | Q41078584 | ||
| Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma. | Q41082105 | ||
| Targeted inhibition of interferon-gamma-dependent intercellular adhesion molecule-1 (ICAM-1) expression using dominant-negative Stat1. | Q41082118 | ||
| STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor | Q41109044 | ||
| Induction of MHC class I expression by the MHC class II transactivator CIITA. | Q41112935 | ||
| Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism | Q41120368 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 1-29 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Pharmacology & Therapeutics | Q3378596 |
| P1476 | title | Alternate interferon signaling pathways | |
| P478 | volume | 100 |
| Q40425770 | A role for mixed lineage kinases in regulating transcription factor CCAAT/enhancer-binding protein-{beta}-dependent gene expression in response to interferon-{gamma}. |
| Q35077047 | Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91 |
| Q42993815 | Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy. |
| Q42813590 | Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes |
| Q33519523 | Coordinated regulation of SIV replication and immune responses in the CNS. |
| Q36540282 | Critical role for transcription factor C/EBP-beta in regulating the expression of death-associated protein kinase 1. |
| Q42857638 | Different physiology of interferon-α/-γ in models of liver regeneration in the rat. |
| Q40262868 | Differential regulation of tumor necrosis factor-alpha-converting enzyme and angiotensin-converting enzyme by type I and II interferons in human normal and leukemic myeloid cells. |
| Q30418061 | Endometrial receptivity defects and impaired implantation in diabetic NOD mice. |
| Q33812026 | Eriobotrya japonica hydrophilic extract modulates cytokines in normal tissues, in the tumor of Meth-A-fibrosarcoma bearing mice, and enhances their survival time. |
| Q21131160 | Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell Types |
| Q39662923 | IL-6-mediated intersubgenotypic variation of interferon sensitivity in hepatitis C virus genotype 2a/2b chimeric clones. |
| Q37987133 | Immunity to fish rhabdoviruses |
| Q34583489 | Inflammation activates the interferon signaling pathways in taste bud cells |
| Q37312123 | Inflammation and taste disorders: mechanisms in taste buds |
| Q29620712 | Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins |
| Q46742743 | Inhibition of matrix metalloproteinase-9 by interferons and TGF-beta1 through distinct signalings accounts for reduced monocyte invasiveness |
| Q35004930 | Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infection |
| Q35886748 | Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma |
| Q34464075 | Interferon-alpha-induced expression of phospholipid scramblase 1 through STAT1 requires the sequential activation of protein kinase Cdelta and JNK. |
| Q39327912 | Interferon-α induces nitric oxide synthase expression and haem oxygenase-1 down-regulation in microglia: implications of cellular mechanism of IFN-α-induced depression |
| Q33988186 | Interferons, signal transduction pathways, and the central nervous system |
| Q37342272 | Interferons: signaling, antiviral and viral evasion |
| Q37547088 | Internal ribosome entry site-based attenuation of a flavivirus candidate vaccine and evaluation of the effect of beta interferon coexpression on vaccine properties |
| Q37482664 | Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma |
| Q36308205 | JAK1 gene polymorphisms are associated with the outcomes of hepatitis B virus infection, but not with α interferon therapy response in a Han Chinese population |
| Q24301649 | Link between the ubiquitin conjugation system and the ISG15 conjugation system: ISG15 conjugation to the UbcH6 ubiquitin E2 enzyme |
| Q24298148 | Negative regulation of protein phosphatase 2Cbeta by ISG15 conjugation |
| Q39832097 | Palmitoylation of interferon-alpha (IFN-alpha) receptor subunit IFNAR1 is required for the activation of Stat1 and Stat2 by IFN-alpha |
| Q33274587 | Recognition of interferon-inducible sites, promoters, and enhancers |
| Q35382729 | Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-γ) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state |
| Q24794178 | Screening of retroviral cDNA libraries for factors involved in protein phosphorylation in signaling cascades |
| Q35117727 | Susceptibility of different hepatitis B virus isolates to interferon-alpha in a mouse model based on hydrodynamic injection |
| Q40288125 | The JAK-STAT signaling network in the human B-cell: an extreme signaling pathway analysis |
| Q37783456 | The fight between the teleost fish immune response and aquatic viruses |
| Q36707747 | The innate antiviral response: new insights into a continuing story |
| Q37046824 | The interferon signaling network and transcription factor C/EBP-beta |
| Q38161832 | Transcription control of DAPK. |
Search more.